"Tranylcypromine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A propylamine formed from the cyclization of the side chain of amphetamine. This monoamine oxidase inhibitor is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in panic and phobic disorders. (From AMA Drug Evaluations Annual, 1994, p311)
| Descriptor ID |
D014191
|
| MeSH Number(s) |
D02.092.831.845
|
| Concept/Terms |
Tranylcypromine- Tranylcypromine
- trans-2-Phenylcyclopropylamine
- trans 2 Phenylcyclopropylamine
|
Below are MeSH descriptors whose meaning is more general than "Tranylcypromine".
Below are MeSH descriptors whose meaning is more specific than "Tranylcypromine".
This graph shows the total number of publications written about "Tranylcypromine" by people in this website by year, and whether "Tranylcypromine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Tranylcypromine" by people in Profiles.
-
Pan D, Mao C, Wang YX. Suppression of gluconeogenic gene expression by LSD1-mediated histone demethylation. PLoS One. 2013; 8(6):e66294.
-
Vytopil M, Mani R, Adlakha A, Zhu JJ. Acute chorea and hyperthermia after concurrent use of modafinil and tranylcypromine. Am J Psychiatry. 2007 Apr; 164(4):684.
-
Keck PE, Carter WP, Nierenberg AA, Cooper TB, Potter WZ, Rothschild AJ. Acute cardiovascular effects of tranylcypromine: correlation with plasma drug, metabolite, norepinephrine, and MHPG levels. J Clin Psychiatry. 1991 Jun; 52(6):250-4.